Rep. April McClain Delaney Sells STERIS plc (NYSE:STE) Stock

Posted by Stanley Muller on Sep 11th, 2026

Representative April McClain Delaney (Democratic-Maryland) recently sold shares of STERIS plc (NYSE:STE). In a filing disclosed on September 09th, the Representative disclosed that they had sold between $100,001 and $250,000 in STERIS stock on August 25th.

Representative April McClain Delaney also recently made the following trade(s):

Sold $100,001 – $250,000 in shares of Wabtec (NYSE:WAB) on 8/25/2026.
Sold $100,001 – $250,000 in shares of Viking (NYSE:VIK) on 8/25/2026.
Sold $100,001 – $250,000 in shares of Trimble (NASDAQ:TRMB) on 8/25/2026.
Sold $100,001 – $250,000 in shares of Transdigm Group (NYSE:TDG) on 8/25/2026.
Sold $15,001 – $50,000 in shares of Tractor Supply (NASDAQ:TSCO) on 8/25/2026.
Sold $15,001 – $50,000 in shares of Middleby (NASDAQ:MIDD) on 8/25/2026.
Sold $15,001 – $50,000 in shares of Teledyne Technologies (NYSE:TDY) on 8/25/2026.
Sold $100,001 – $250,000 in shares of Somnigroup International (NYSE:SGI) on 8/25/2026.
Sold $100,001 – $250,000 in shares of Signet Jewelers (NYSE:SIG) on 8/25/2026.
Sold $100,001 – $250,000 in shares of Paychex (NASDAQ:PAYX) on 8/25/2026.

STERIS Stock Down 0.6%

STE stock traded down $1.35 during midday trading on Friday, reaching $211.10. 595,400 shares of the company were exchanged, compared to its average volume of 560,440. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.35 and a current ratio of 1.91. STERIS plc has a 1-year low of $195.14 and a 1-year high of $269.44. The stock’s 50-day simple moving average is $225.55 and its 200 day simple moving average is $221.14. The company has a market cap of $20.58 billion, a price-to-earnings ratio of 25.81 and a beta of 0.91.

STERIS (NYSE:STE – Get Free Report) last issued its earnings results on Wednesday, August 5th. The medical equipment provider reported $2.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.49 by $0.10. STERIS had a net margin of 13.34% and a return on equity of 14.34%. The business had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.49 billion. During the same quarter in the prior year, the business posted $2.34 EPS. The company’s revenue for the quarter was up 7.3% on a year-over-year basis. STERIS has set its FY 2027 guidance at 11.000-11.300 EPS. On average, equities analysts forecast that STERIS plc will post 11.09 earnings per share for the current year.

STERIS Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Friday, September 4th will be paid a $0.69 dividend. This is an increase from STERIS’s previous quarterly dividend of $0.63. This represents a $2.76 annualized dividend and a yield of 1.3%. The ex-dividend date is Friday, September 4th. STERIS’s payout ratio is currently 33.74%.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. Piper Sandler reissued an “overweight” rating and issued a $275.00 target price (up from $270.00) on shares of STERIS in a report on Friday, August 7th. Wall Street Zen upgraded STERIS from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. UBS Group lowered their target price on shares of STERIS from $275.00 to $270.00 and set a “buy” rating on the stock in a research report on Friday, August 7th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of STERIS in a report on Monday, August 24th. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, STERIS presently has an average rating of “Moderate Buy” and an average target price of $271.33.

View Our Latest Analysis on STE

Institutional Investors Weigh In On STERIS

Several large investors have recently modified their holdings of STE. Western Wealth Management LLC purchased a new position in STERIS during the 1st quarter worth $25,000. Elevation Wealth Partners LLC increased its stake in shares of STERIS by 1,130.0% during the second quarter. Elevation Wealth Partners LLC now owns 123 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 113 shares during the period. Measured Wealth Private Client Group LLC acquired a new position in shares of STERIS during the fourth quarter worth about $28,000. Geneos Wealth Management Inc. raised its holdings in STERIS by 416.0% during the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 104 shares in the last quarter. Finally, Meramec Financial Planners LLC acquired a new stake in STERIS in the first quarter valued at about $33,000. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Insider Buying and Selling

In other news, Director Mohsen Sohi sold 4,058 shares of the stock in a transaction that occurred on Wednesday, August 12th. The stock was sold at an average price of $235.78, for a total transaction of $956,795.24. Following the completion of the transaction, the director directly owned 24,305 shares of the company’s stock, valued at approximately $5,730,632.90. This represents a 14.31% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP John Zangerle sold 1,419 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $209.28, for a total value of $296,968.32. Following the completion of the sale, the vice president directly owned 35,259 shares of the company’s stock, valued at $7,379,003.52. This represents a 3.87% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.12% of the stock is currently owned by insiders.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland’s 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland’s 6th Congressional District. She declared candidacy for the 2026 election.

April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor’s degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

About STERIS

(Get Free Report)

STERIS plc (NYSE: STE) is a global provider of products and services designed to support infection prevention, sterilization, surgical procedures and other critical healthcare and life sciences activities. The company serves hospitals, ambulatory surgery centers, dental practices, pharmaceutical and biotechnology manufacturers, medical device companies, and research organizations.

Its offerings include sterilizers, washers, surgical tables and lights, operating-room equipment, endoscopy products, infection-prevention consumables, and related maintenance and technical services.